Visible results in 4-8 weeks
Signs you may need to increase dose: minimal improvement after 4 weeks of consistent use, rapid healing that could progress further, or previous positive response to higher doses of related peptides
Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells
The peptide is metabolized primarily by hepatic cytochrome P450 enzymes, with metabolites excreted renally
1 Introduction Neurodegenerative diseases (NDDs) comprise a heterogeneous group of disorders characterized by the progressive loss of neurons or myelin in the brain and spinal cord, including Alzheimers disease (AD), Parkinsons disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and Huntingtons disease (HD) (Wilson et al., 2023)
The tissue-repair literature also extends conceptually toward nerve and other tissue types